Detalhe da pesquisa
1.
An Epidemiology Model for Estimating the Numbers of US Patients With Multiple Myeloma by Line of Therapy and Treatment Exposure.
Value Health
; 25(12): 1977-1985, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35963840
2.
External Validation of Health Economic Decision Models for Chronic Obstructive Pulmonary Disease (COPD): Report of the Third COPD Modeling Meeting.
Value Health
; 20(3): 397-403, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28292484
3.
Patient Heterogeneity in Health Economic Decision Models for Chronic Obstructive Pulmonary Disease: Are Current Models Suitable to Evaluate Personalized Medicine?
Value Health
; 19(6): 800-810, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27712708
4.
Cost-effectiveness models for chronic obstructive pulmonary disease: cross-model comparison of hypothetical treatment scenarios.
Value Health
; 17(5): 525-36, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25128045
5.
Feasibility Study of a Network Meta-Analysis and Unanchored Population-Adjusted Indirect Treatment Comparison of Niraparib, Olaparib, and Bevacizumab as Maintenance Therapies in Patients with Newly Diagnosed Advanced Ovarian Cancer.
Cancers (Basel)
; 14(5)2022 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35267593
6.
Budget Impact of Belantamab Mafodotin (Belamaf) Adoption in the Treatment of Patients with Relapsed or Refractory Multiple Myeloma in the United States.
Clinicoecon Outcomes Res
; 13: 789-800, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34531667
7.
Belantamab mafodotin for the treatment of relapsed/refractory multiple myeloma in heavily pretreated patients: a US cost-effectiveness analysis.
Expert Rev Hematol
; 14(12): 1137-1145, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34465265
8.
Cost-effectiveness of stroke unit care followed by early supported discharge.
Stroke
; 40(1): 24-9, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19008473
9.
Utilising artificial intelligence to determine patients at risk of a rare disease: idiopathic pulmonary arterial hypertension.
Pulm Circ
; 9(4): 2045894019890549, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31798836
10.
High levels of healthcare utilization prior to diagnosis in idiopathic pulmonary arterial hypertension support the feasibility of an early diagnosis algorithm: the SPHInX project.
Pulm Circ
; 8(4): 2045894018798613, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30187824
11.
Cost-effectiveness of roflumilast as an add-on treatment to long-acting bronchodilators in the treatment of COPD associated with chronic bronchitis in the United Kingdom.
Eur J Health Econ
; 15(1): 69-82, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23392624
12.
Cost-effectiveness of roflumilast in combination with bronchodilator therapies in patients with severe and very severe COPD in Switzerland.
Int J Chron Obstruct Pulmon Dis
; 8: 79-87, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23386787
13.
Long-term clinical and economic outcomes associated with liraglutide versus sitagliptin therapy when added to metformin in the treatment of type 2 diabetes: a CORE Diabetes Model analysis.
J Med Econ
; 15 Suppl 2: 28-37, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22834986
14.
Long-term cost-utility analysis of exenatide once weekly versus insulin glargine for the treatment of type 2 diabetes patients in the US.
J Med Econ
; 15 Suppl 2: 6-13, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22793669
15.
Cost-effectiveness of available treatment options for patients suffering from severe COPD in the UK: a fully incremental analysis.
Int J Chron Obstruct Pulmon Dis
; 7: 183-99, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22500119
16.
Long-term cost-consequence analysis of exenatide once weekly vs sitagliptin or pioglitazone for the treatment of type 2 diabetes patients in the United States.
J Med Econ
; 15(4): 654-63, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22369345
17.
Modeling the lifetime costs of insulin glargine and insulin detemir in type 1 and type 2 diabetes patients in Canada: a meta-analysis and a cost-minimization analysis.
J Med Econ
; 14(2): 207-16, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21361858
18.
Mental health care reforms in Europe: Rehabilitation and social inclusion of people with mental illness in Russia.
Psychiatr Serv
; 61(3): 222-4, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20194396
19.
Mental health reform in the Russian Federation: an integrated approach to achieve social inclusion and recovery.
Bull World Health Organ
; 85(11): 858-66, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18038076
20.
Health-systems efficiency in the Russian Federation: tuberculosis control.
Bull World Health Organ
; 84(1): 43-51, 2006 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16501714